Premium
Early increase of serum alpha‐fetoprotein in spontaneous hepatocarcinogenesis in mice
Author(s) -
Jalanko H.,
Virtanen I.,
Engvall E.,
Ruoslahti E.
Publication year - 1978
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910210409
Subject(s) - alpha (finance) , alpha fetoprotein , biology , medicine , endocrinology , surgery , hepatocellular carcinoma , construct validity , patient satisfaction
Abstract The concentration of serum alpha‐fetoprotein (AFP) was followed in C3H mice having a high incidence of spontaneous liver‐cell cancer. No general elevation of serum AFP level with age was seen in mice without tumor. With a single exception, mice bearing hepatocellular carcinomas had increased serum AFP levels. In some mice this increase followed a biphasic course. Mice killed within 1 month of the time when an elevation of serum AFP was first observed had small tumors or no detectable tumor. Premalignant lesions were present in the livers of 11 out of 16 mice that had elevated AFP but no cancer, while only one out of 14 mice with normal AFP had such alterations. Our results strongly suggest that spontaneous hepatocarcinogenesis proceeds through almost the same premalignant lesions as chemically induced carcinogenesis, and that an increase in AFP production occurs early during this process, often preceding macroscopic lesions. Autologous antibodies to AFP were produced in a group of C3H mice by immunization with rat AFP. These anti‐AFP antibodies reduced the amount of serum AFP but had no effect on the incidence of spontaneous hepatomas.